Advil Liqui-Gels
- Product NDC
- 52904-793
- 11-digit product format
- 529040793
- Labeler code
- 52904
- Product ID
- 52904-793_82793c1b-9e91-43a4-bb62-9ba3af327682
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Ibuprofen
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Select Corporation
- Application
- NDA020402
- Marketing category
- NDA
- Marketing start
- 2003-02-28
- Marketing end
- 0000-00-00
- Substance
- IBUPROFEN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 52904-793 | I | Inactivated by FDA | 2026-08-10 | ||
| excluded package | package | 52904-793 | 52904-793-04 | I | Inactivated by FDA | 2026-08-10 | |
| excluded package | package | 52904-793 | 52904-793-05 | I | Inactivated by FDA | 2026-08-10 | |
| excluded package | package | 52904-793 | 52904-793-25 | I | Inactivated by FDA | 2026-08-10 | |
| excluded package | package | 52904-793 | 52904-793-30 | I | Inactivated by FDA | 2026-08-10 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 52904-793-30 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 52904-793-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 52904-793-25 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 52904-793-04 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 52904-793-30 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 52904-793-05 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 52904-793-25 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 52904-793-04 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 52904-793-30 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 52904-793-05 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 52904-793-25 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 52904-793-04 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 52904-793-30 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 52904-793-05 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 52904-793-25 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 52904-793-04 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 52904-793-30 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 52904-793-05 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 52904-793-25 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 52904-793-04 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 52904-793-30 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 52904-793-05 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 52904-793-25 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 52904-793-04 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 52904-793-30 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 52904-793-05 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 52904-793-25 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 52904-793-04 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 52904-793-30 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 52904-793-05 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 52904-793-25 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 52904-793-04 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 52904-793-30 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 52904-793-05 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 52904-793-25 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 52904-793-04 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 52904-793-30 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 52904-793-05 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 52904-793-25 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 52904-793-04 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 52904-793-30 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 52904-793-05 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 52904-793-25 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 52904-793-04 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 52904-793-30 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 52904-793-05 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 52904-793-25 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 52904-793-04 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020402-001 | ADVIL LIQUI-GELS | IBUPROFEN | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | |
| N020402-002 | ADVIL MIGRAINE LIQUI-GELS | IBUPROFEN | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 782e0a99824c… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Related label |
|---|---|
| 52904-793-04 | Advil ® Liqui-Gels ® |
| 52904-793-05 | Advil ® Liqui-Gels ® |
| 52904-793-25 | Advil ® Liqui-Gels ® |
| 52904-793-30 | Advil ® Liqui-Gels ® |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52904-793-04 | Advil Liqui-Gels | 1 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 1 | 2 | |
| 52904-793-04 | Advil Liqui-Gels | 2 in 1 POUCH | CAPSULE, LIQUID FILLED | 2 | 2 | |
| 52904-793-05 | Advil Liqui-Gels | 2 in 1 POUCH | CAPSULE, LIQUID FILLED | 2 | 2 | |
| 52904-793-05 | Advil Liqui-Gels | 2 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 2 | 2 | |
| 52904-793-25 | Advil Liqui-Gels | 25 in 1 CARTON | CAPSULE, LIQUID FILLED | 25 | 2 | |
| 52904-793-25 | Advil Liqui-Gels | 2 in 1 POUCH | CAPSULE, LIQUID FILLED | 2 | 2 | |
| 52904-793-30 | Advil Liqui-Gels | 30 in 1 CARTON | CAPSULE, LIQUID FILLED | 30 | 2 | |
| 52904-793-30 | Advil Liqui-Gels | 2 in 1 POUCH | CAPSULE, LIQUID FILLED | 2 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ADVIL MIGRAINE | IBUPROFEN | Haleon US Holdings LLC | e4a6219d-4ad4-0119-4cf8-7fc39b4b5979 | 2026-07-29 | Warnings | 020402 NDA020402 |
| Advil | IBUPROFEN | Haleon US Holdings LLC | 1f01c10a-9434-91a4-2ee4-352315a6b610 | 2026-07-29 | Warnings | 020402 NDA020402 |
| Advil Liquigel | IBUPROFEN | Select Consumer Group | 3ca6bc9d-090f-e412-e063-6394a90a6876 | 2026-07-03 | Warnings | 020402 NDA020402 |
| Advil Liqui-Gels | IBUPROFEN CAPSULE, LIQUID-FILLED | Lil' Drug Store Products, Inc. | c459ea1e-dabf-bba6-e053-2995a90af40f | 2024-12-30 | Warnings | 020402 NDA020402 |
| Advil Liqui-Gels | IBUPROFEN | Lil Drug Store Products, Inc | ba5a9a04-993e-4fd6-bb40-6edfdfb69b34 | 2024-03-27 | Warnings | 020402 NDA020402 |
| Advil Liquigels | IBUPROFEN | Navajo Manufacturing Company Inc. | e2c09216-fd63-4d50-9878-62b36236b2e7 | 2023-03-15 | Warnings | 020402 NDA020402 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 731533 | Advil 200 MG Oral Capsule | PSN | 9fce41c2-e059-4180-9e7b-47ac506baf44 | 2 |
| 310964 | ibuprofen 200 MG Oral Capsule | PSN | 9fce41c2-e059-4180-9e7b-47ac506baf44 | 2 |
| 731533 | ibuprofen 200 MG Oral Capsule [Advil] | SBD | 9fce41c2-e059-4180-9e7b-47ac506baf44 | 2 |
| 310964 | ibuprofen 200 MG Oral Capsule | SCD | 9fce41c2-e059-4180-9e7b-47ac506baf44 | 2 |
| 731533 | Advil 200 MG Oral Capsule | SY | 9fce41c2-e059-4180-9e7b-47ac506baf44 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 52904-793-04 | 52904079304 | 1 POUCH in 1 BLISTER PACK (52904-793-04) > 2 CAPSULE, LIQUID FILLED in 1 POUCH | 1 pouch | 2003-02-28 | 0000-00-00 | No | No | Current |
| 52904-793-05 | 52904079305 | 2 POUCH in 1 BLISTER PACK (52904-793-05) > 2 CAPSULE, LIQUID FILLED in 1 POUCH | 2 pouch | 2003-02-28 | 0000-00-00 | No | No | Current |
| 52904-793-25 | 52904079325 | 25 POUCH in 1 CARTON (52904-793-25) > 2 CAPSULE, LIQUID FILLED in 1 POUCH | 25 pouch | 2003-02-28 | 0000-00-00 | No | No | Current |
| 52904-793-30 | 52904079330 | 30 POUCH in 1 CARTON (52904-793-30) > 2 CAPSULE, LIQUID FILLED in 1 POUCH | 30 pouch | 2003-02-28 | 0000-00-00 | No | No | Current |